Product Code: NE02-01-00-00-00
Molecular Methods Present Significant Opportunities
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalence of these diseases and the growing demand for rapid diagnostic tests. Regional breakdowns are provided for three market segments: immunodiagnostics, molecular methods, and clinical microbiology. Regional breakdowns by disease also are provided. The base year for the study is 2013; the forecast period is from 2014 to 2018.
Key Questions This Study Will Answer
- What are some of the game-changing strategies for global market participants?
- What are the key market drivers and restraints?
- Who are the market leaders, and how are they overcoming industry challenges?
- What are the unmet market needs, and how are market participants working to meet these needs?
- Which diseases contribute significantly to market revenue in the United States and Western Europe?
- What are the fastest-growing market segments? Is growth sustainable over the next 5 years?
Table of Contents
1. EXECUTIVE SUMMARY
Executive Summary
- 1. Key Findings
- 2. Key Findings (continued)
- 3. Scope and Segmentation
- 4. Top Diseases by Region
- 5. Diseases and Available Solutions in the Global Market
- 6. Key Questions This Study Will Answer
- 7. Measurements
- 8. CEO's Perspective
- 9. Key Companies to Watch
- 10. Executive Summary-3 Big Predictions
2. MARKET OVERVIEW
Market Overview
- 1. Market Background-Infectious Diseases
- 2. Disease Background-Sepsis
- 3. Disease Background-TB
- 4. Disease Background-MRSA
- 5. Disease Background-Hepatitis B and C
- 6. Disease Background-Hepatitis B and C (continued)
- 7. Disease Background-Hantavirus
- 8. Market Segmentation-Definitions
- 9. Market Segmentation
- 10. Healthcare Trends
3. COMPETITIVE PLAYBOOK
Competitive Playbook
- 1. Solutions Provided for Each Disease
- 2. New Market Opportunities
- 3. New Market Opportunities (continued)
- 4. New Market Opportunities (continued)
- 5. Merger, Acquisition, and Partnership Assessment
- 6. Merger, Acquisition, and Partnership Assessment (continued)
- 7. Merger, Acquisition, and Partnership Assessment (continued)
4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL INFECTIOUS DISEASE DIAGNOSTICS MARKET
Drivers, Restraints, and Trends-Total Infectious Disease Diagnostics Market
- 1. Market Drivers
- 2. Market Restraints
5. FORECAST AND TRENDS-TOTAL INFECTIOUS DISEASE DIAGNOSTICS MARKET
Forecast and Trends-Total Infectious Disease Diagnostics Market
- 1. Measurements
- 2. Forecast Assumptions and Definitions
- 3. Revenue Forecast
- 4. Revenue Forecast Discussion
- 5. Percent Revenue Forecast by Region
- 6. Revenue Forecast by Region
- 7. Percent Revenue Forecast by Segment
- 8. Revenue Forecast by Segment
- 9. Revenue Forecast by Segment Discussion
- 10. Revenue Forecast by Segment Discussion (continued)
- 11. Revenue Forecast by Segment Discussion (continued)
- 12. Segment Lifecycle Analysis
6. COMPETITIVE ENVIRONMENT
Competitive Environment
- 1. Competitive Environment
- 2. Marketed Product Analysis-TB
- 3. Marketed Product Analysis-TB (continued)
- 4. Marketed Product Analysis-Sepsis
- 5. Marketed Product Analysis-MRSA
- 6. Marketed Product Analysis-Hepatitis B/C
- 7. Marketed Product Analysis-Hepatitis B/C (continued)
- 8. Top Competitors
- 9. Top Competitors (continued)
- 10. Top Competitors (continued)
7. US MARKET ANALYSIS
US Market Analysis
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast by Disease
- 4. Revenue Forecast Discussion
- 5. Revenue Forecast by Segment
- 6. Revenue Forecast by Segment Discussion
- 7. Revenue Forecast by Segment Discussion (continued)
- 8. Revenue Forecast by Segment Discussion (continued)
- 9. US-Market Analysis
- 10. PESTLE Analysis
- 11. Market Impact of Top Trends
- 12. US-Market Share by Tier
- 13. US-Tier Analysis
- 14. US-Tier Analysis (continued)
- 15. US-Tier Analysis (continued)
8. WESTERN EUROPE MARKET ANALYSIS
Western Europe Market Analysis
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast by Disease
- 4. Revenue Forecast Discussion
- 5. Revenue Forecast by Segment
- 6. Revenue Forecast by Segment Discussion
- 7. Revenue Forecast by Segment Discussion (continued)
- 8. Revenue Forecast by Segment Discussion (continued)
- 9. PESTLE Analysis
- 10. Market Impact of Top Trends
- 11. Western Europe-Market Analysis
- 12. Western Europe-Market Share by Tier
- 13. Western Europe-Tier Analysis
- 14. Western Europe-Tier Analysis (continued)
- 15. Western Europe-Tier Analysis (continued)
9. APAC & ROW MARKET ANALYSIS
APAC & ROW Market Analysis
- 1. Measurements
- 2. Revenue Forecast
- 3. Revenue Forecast Discussion
- 4. Revenue Forecast by Segment
- 5. Revenue Forecast by Segment Discussion
- 6. Revenue Forecast by Segment Discussion (continued)
- 7. Revenue Forecast by Segment Discussion (continued)
- 8. PESTLE Analysis
- 9. Market Impact of Top Trends
- 10. APAC & ROW-Market Analysis
- 11. APAC & ROW-Market Share by Tier
- 12. APAC & ROW-Tier Analysis
- 13. APAC & ROW-Tier Analysis
10. KEY COMPANIES TO WATCH
Key Companies to Watch
- 1. Reagena
- 2. Nanomix
- 3. Anagnostics GmbH
11. THE LAST WORD
The Last Word
- 1. The Last Word-3 Big Predictions
- 2. The Last Word-Discussion
- 3. The Last Word-Discussion (continued)
- 4. The Last Word-Discussion (continued)
- 5. Legal Disclaimer
12. APPENDIX
Appendix
- 1. Drivers Explained
- 2. Drivers Explained (continued)
- 3. Restraints Explained
- 4. Restraints Explained (continued)
- 5. Restraints Explained (continued)
- 6. List of Other Companies-United States
- 7. List of Other Companies-Western Europe
- 8. List of Other Companies-APAC and ROW
- 9. Associated Multimedia
- 10. Associated Multimedia (continued)
- 11. Methodology
- 12. List of Exhibits
- 13. List of Exhibits (continued)
- 14. List of Exhibits (continued)
- 15. List of Exhibits (continued)
List of Exhibits
- Total Infectious Disease Diagnostics Market: Diseases Covered by Each Region, Global, 2013
- Total Infectious Disease Diagnostics Market: Diagnostic Testing Availability by Segment, Global, 2013
- Total Infectious Disease Diagnostics Market: Market Engineering Measurements, Global, 2013
- Total Infectious Disease Diagnostics Market: Key Definitions, Global, 2013
- Total Infectious Disease Diagnostics Market: Market Segmentation, Global, 2013
- Total Infectious Disease Diagnostics Market: Market Outlook, Global, 2013 and 2023
- Total Infectious Disease Diagnostics Market: Company Offerings, Global, 2013
- Total Infectious Disease Diagnostics Market: Game-changing Strategies, Global, 2013
- Total Infectious Disease Diagnostics Market: Acquisitions and Partnerships, Global, 2013
- Total Infectious Disease Diagnostics Market: Key Market Drivers, Global, 2014-2018
- Total Infectious Disease Diagnostics Market: Key Market Restraints, Global, 2014-2018
- Total Infectious Disease Diagnostics Market: Market Engineering Measurements, Global, 2013
- Total Infectious Disease Diagnostics Market: Revenue Forecast, Global, 2011-2018
- Total Infectious Disease Diagnostics Market: Percent Revenue Forecast by Region, Global, 2011-2018
- Total Infectious Disease Diagnostics Market: Revenue Forecast by Region, 2011-2018
- Total Infectious Disease Diagnostics Market: Percent Revenue Forecast by Segment, Global, 2011-2018
- Total Infectious Disease Diagnostics Market: Revenue Forecast by Segment, Global, 2011-2018
- Total Infectious Disease Diagnostics Market: Segment Lifecycle Analysis, Global, 2013
- Total Infectious Disease Diagnostics Market: Competitive Structure, Global, 2013
- Total Infectious Disease Diagnostics Market: Marketed Product Analysis (TB), Global, 2013
- Total Infectious Disease Diagnostics Market: Marketed Product Analysis Sepsis), Global, 2013
- Total Infectious Disease Diagnostics Market: Marketed Product Analysis (MRSA), Global, 2013
- Total Infectious Disease Diagnostics Market: Marketed Product Analysis (Hepatitis B/C), Global, 2013
- Total Infectious Disease Diagnostics Market: SWOT Analysis, Global, 2013
- Infectious Disease Diagnostics Market: Market Engineering Measurements, US, 2013
- Infectious Disease Diagnostics Market: Revenue Forecast, US. 2011-2018
- Infectious Disease Diagnostics Market: Revenue Forecast by Disease, US, 2011-2018
- Infectious Disease Diagnostics Market: Revenue Forecast by Segment, US, 2011-2018
- Infectious Disease Diagnostics Market: PESTLE Analysis, US, 2013
- Infectious Disease Diagnostics Market: Impact of Top 5 Trends, US, 2013
- Infectious Disease Diagnostics Market: Market Share Analysis, US, 2013
- Infectious Disease Diagnostics Market: Market Engineering Measurements, Western Europe, 2013
- Infectious Disease Diagnostics Market: Revenue Forecast, Western Europe, 2011-2018
- Infectious Disease Diagnostics Market: Revenue Forecast by Disease, Western Europe, 2011-2018
- Infectious Disease Diagnostics Market: Revenue Forecast by Segment, Western Europe, 2011-2018
- Infectious Disease Diagnostics Market: PESTLE Analysis, Western Europe, 2013
- Infectious Disease Diagnostics Market: Impact of Top 5 Trends, Western Europe, 2013
- Infectious Disease Diagnostics Market: Market Share Analysis, Western Europe, 2013
- Infectious Disease Diagnostics Market: Market Engineering Measurements, APAC & ROW, 2013
- Infectious Disease Diagnostics Market: Revenue Forecast, APAC & ROW, 2011-2018
- Infectious Disease Diagnostics Market: Revenue Forecast by Segment, APAC & ROW, 2011-2018
- Infectious Disease Diagnostics Market: PESTLE Analysis, APAC & ROW, 2013
- Infectious Disease Diagnostics Market: Impact of Top 5 Trends, APAC & ROW, 2013
- Infectious Disease Diagnostics Market: Market Share Analysis, APAC & ROW, 2013